Umama Alam, Shree Rath, Muhammad Ansab, Amar Lal. "High-dose furmonertinib in
                    <i>EGFR</i>
                    -mutant NSCLC with brain metastases after EGFR-TKI resistance.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.e14028